{ "items": [ "\n\n
\n \n 20 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle\u2019s Global Pathogen Analysis System (GPAS) is now being used by organisations on nearly every continent.
\n \n\n\n \n 2 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA new Oxford University Study, published today, shows that the most recent common ancestor of coronavirus existed more than 21,000 years ago, nearly 30 times older than previous estimates.
\n \n\n\n \n 1 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nFor the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria.
\n \n\n\n \n 25 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Royal Society Africa Prize 2021 is awarded to Professor George Warimwe for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. This Prize recognises research scientists based in Africa who are making an innovative contribution to the sciences.
\n \n\n\n \n 24 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA national study has found that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions, mount a low, or undetectable, immune response after two doses of the same COVID-19 vaccine.
\n \n\n\n \n 4 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) \u2013 of which the University of Oxford is a lead partner \u2013 announced today the start of vaccinations in a Phase I clinical trial of a novel HIV vaccine candidate.
\n \n\n\n \n 26 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.
\n \n\n\n \n 21 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nAn international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues report the unequal impacts of public health measures, and the prevalence of \u2018fake news\u2019.
\n \n\n\n \n 16 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nAdenovirus vaccine vectors, such as the ChAdOx1 nCov-19 construct which has risen to prominence as a major vaccine for COVID-19, may generate robust long-term immune system responses, according to scientists from the Universities of Oxford and the Cantonal Hospital St.Gallen, Switzerland
\n \n\n\n \n 12 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nNDM's Jenner Institute today started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.
\n \n\n\n \n 16 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe RECOVERY Trial, the world\u2019s largest randomised trial of potential COVID-19 treatments, has found that a monoclonal antibody combination developed by US company Regeneron reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response.
\n \n\n\n \n 11 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.
\n \n\n\n \n 28 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has today announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. The Pandemic Sciences Centre will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats.
\n \n\n\n \n 21 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has been named David Sackett Trial of the Year by the Society for Clinical Trials (SCT). The award was presented today at the Society for Clinical Trials\u2019 42nd Annual Meeting.
\n \n\n\n \n 17 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.
\n \n\n\n \n 12 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Academy of Medical Sciences has elected 11 University of Oxford biomedical and health scientists to its fellowship five of which are from the Nuffield Department of Medicine. All were selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.
\n \n\n\n \n 10 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Adrian Hill, Director of the Jenner Institute becomes a Fellow for his leading role in the design and development of new vaccines for globally important infectious diseases over the course of over 25 years. He has demonstrated that non-replicating vectored vaccines, particularly simian adenoviruses used in heterologous prime-boost immunisation regimes, can protect safely through cellular as well as humoral immunity \u2013 supporting new vaccination approaches for malaria and Ebola.
\n \n\n\n \n 23 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nData from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR\u2019s COVID-19 urgent public health studies, is a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC).
\n \n\n\n \n 14 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nYou are cordially invited to join the CCOUC Webinar on Health-EDRM Education and Research in China: Commemorating the 512 Wenchuan Earthquake. As a commemoration of the 512 Wenchuan Earthquake in 2008, experts will share with you an update on the latest Health-EDRM Education and Research in China. This is a webinar of the CCOUC 10th Anniversary International Webinar Series on Health Emergency and Disaster Risk Management.
\n \n\n\n \n 6 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe new easy-to-produce test detects coronavirus spike-protein binding antibodies in people who have tested positive for COVID-19.
\n \n\n